Alethia Biotherapeutics

Montreal, Canada · Founded 2002 · $16.5M raised

Headquarters
Montreal
Employees
11–50
Founded
2002
Business Model
B2B
Total Funding
$16.5M
Last Round
$4.7M Series COct 2024
Rounds
5

About

Alethia Biotherapeutics is a privately held, Montreal-based clinical-stage biotechnology company founded in 2002. The company is engaged in the discovery and development of therapeutic monoclonal antibodies against novel, clinically relevant targets in cancer and inflammatory diseases, with a focus on cancer-associated epithelial-to-mesenchymal transition (EMT) pathways.

Summary

Alethia Biotherapeutics is a Biotech company based in Montreal, Canada, founded in 2002. It has raised $16.5M in total across 5 rounds, most recently a $4.7M Series C round in Oct 2024. Investors include BDC Venture Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries COct 2024

Sign up to see all 5 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alethia Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alethia-biotherapeutics"><img src="https://indexed.vc/api/badge/company/alethia-biotherapeutics" alt="Alethia Biotherapeutics on Indexed.vc" width="260" height="76" /></a>